coumarin has been researched along with Aura in 2 studies
2H-chromen-2-one: coumarin derivative
Excerpt | Relevance | Reference |
---|---|---|
"Antiepileptic drugs are the mainstream treatment for epilepsy; however, the drug resistance occurring in 20-30% of patients and side effects of available medications have resulted in a search for natural remedies that can support disease therapy." | 6.61 | Coumarins as potential supportive medication for the treatment of epilepsy. ( Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M, 2019) |
"Antiepileptic drugs are the mainstream treatment for epilepsy; however, the drug resistance occurring in 20-30% of patients and side effects of available medications have resulted in a search for natural remedies that can support disease therapy." | 2.61 | Coumarins as potential supportive medication for the treatment of epilepsy. ( Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryda, J | 1 |
Zagaja, M | 1 |
Szewczyk, A | 1 |
Andres-Mach, M | 1 |
Sotaniemi, EA | 1 |
Rautio, A | 1 |
Bäckstrom, M | 1 |
Arvela, P | 1 |
Pelkonen, O | 1 |
1 review available for coumarin and Aura
Article | Year |
---|---|
Coumarins as potential supportive medication for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Brain; Coumarins; Disease Models, Animal; Epilepsy; Humans; Seizures | 2019 |
1 other study available for coumarin and Aura
Article | Year |
---|---|
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
Topics: Administration, Oral; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Capsules; Coumarins; Cytochrome P- | 1995 |